All filters
Slidesets
David Barry DART Achievement Award Lecture: The Discovery of SIV and Development of Monkey Models for the Study of HIV/ AIDS | Ronald Desrosiers, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Differential responses of memory CD4+ T cell subsets to HIV latency reversing agents | D. Kulpa
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) HIV-1 dynamics under integrase inhibitor therapy suggests a subset of cells with slow integration | R.M. Ribeiro
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Impact of Jak Inhibitors on HIV Reservoir Maintenance, Lifespan and Expansion in Primary T Cells and Macrophages | Christina Gavegnano, PhD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Current Clinical Therapies for HIV Remission | David Margolis, MD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Anti–HIV drug candidate abx464 prevents intestinal inflammation by producing IL22 in activated macrophages | J. Tazi
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Gertrude Elion Distinguished Lecturer Award Lecture Stories on Scientific Discoveries that Transformed HIV into a Manageable Disease | Mark Wainberg, MD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Development of a protease inhibitor-based single-tablet complete HIV-1 regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (DCFTAF) | B. Baugh
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
(Abstract) Antiviral Activity of tenofovir alafenamide against HIV-1 with thymidine analog mutation(s) and M184V | C. Callebaut
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Management of Neurocognitive Impairment of Aging Populations Living with HIV | Scott Letendre, MD
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Collateral Damage with Antiviral Therapy | David Thomas, MD, MPH
Presented at:
HIV DART and Emerging Viruses 2016
Slidesets
Minimising treatment duration and doses | Jordan Feld, MD, MPH
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Community and harm reduction response to infection and reinfection | Eberhard Schatz
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Financial models for high- and low income countries | Pieter Walhof
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Role of generic drugs | Andrew Hill, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Building global capacity | Stefano Vella
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - the Netherlands | Anouk Urbanus
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National perspectives in Europe - common themes and challenges | Angelos Hatzakis, MD, PhD, MSc
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - Egypt | Wahid Doss, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - US | John Ward, MD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
National Programs - Australia | Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Progress towards elimination in the Australian prison sector | Andrew Lloyd, MBBS, MD, FRACP, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
People who inject drugs | Olav Dalgard
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016
Slidesets
Children & Pregnant Women | Manal El-Sayed, MD, PhD
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2016